{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:23:39Z","timestamp":1753885419586,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560070"],"award-info":[{"award-number":["81560070"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Previous studies suggested that baseline white blood cell count and apolipoprotein A1 levels were associated with clinical outcomes in patients with coronary heart disease (CAD) who underwent percutaneous coronary intervention (PCI). However, the ratio of baseline white blood cell count-to-apolipoprotein A1 level (WAR) and CAD after PCI have not been investigated. The present study investigated the effects of baseline WAR on long-term outcomes after PCI in patients with CAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 6050 patients with CAD who underwent PCI were included in the study. Of these, 372 patients were excluded because no baseline white blood cell counts or apolipoprotein A1 (ApoA1) data was available or because of malignancies or other diseases. Finally, 5678 patients were enrolled in the present study and were divided into 3 groups according to WAR value: lower group - WAR&lt;\u20095.25 (<jats:italic>n<\/jats:italic>\u2009=\u20091889); median group - 5.25\u2009\u2264\u2009WAR\u22647.15 (<jats:italic>n<\/jats:italic>\u2009=\u20091892); and higher group - WAR\u22657.15 (<jats:italic>n<\/jats:italic>\u2009=\u20091897). The primary endpoint was long-term mortality, including all-cause mortality (ACM) and cardiac mortality (CM), after PCI. The average follow-up time was 35.9\u2009\u00b1\u200922.6\u2009months.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 293 patients developed ACM, including 85 (4.5%) patients in the lower group, 90 (4.8%) patients in the median group, and 118 (6.2%) patients in the higher group. The risk of ACM, cardiac mortality (CM), major adverse cardiovascular and cerebrovascular events (MACCEs), and major adverse cardiovascular events (MACEs) increased 62.6% (hazard risk [HR] =1.626, 95%CI: 1.214\u20132.179, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), 45.5% (HR\u2009=\u20091.455, 95%CI: 1.051\u20132.014, <jats:italic>P<\/jats:italic>\u2009=\u20090.024), 21.2% (HR\u2009=\u20091.212, 95%CI: 1.011\u20131.454, <jats:italic>P<\/jats:italic>\u2009=\u20090.038), and 23.8% (HR\u2009=\u20091.238, 95%CI: 1.025\u20131.495, <jats:italic>P<\/jats:italic>\u2009=\u20090.027), respectively, as determined by multivariate Cox regression analyses comparing the patients in the higher group to patients in the lower group. Patients with a WAR\u22654.635 had 92.3, 81.3, 58.1 and 58.2% increased risks of ACM, CM, MACCEs and MACEs, respectively, compared to the patients with WAR&lt;\u20094.635. Every 1 unit increase in WAR was associated with 3.4, 3.2, 2.0 and 2.2% increased risks of ACM, CM, MACCEs and MACEs, respectively, at the 10-year follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The present study indicated that baseline WAR is a novel and an independent predictor of adverse long-term outcomes in CAD patients who underwent PCI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-020-01206-w","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T12:05:01Z","timestamp":1584360301000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Baseline white blood cell count-to-apolipoprotein A1 ratio as a novel predictor of long-term adverse outcomes in patients who underwent percutaneous coronary intervention: a retrospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Ying","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Geng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Tong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5555-8488","authenticated-orcid":false,"given":"Xiang","family":"XIE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"key":"1206_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nature03862","volume":"306","author":"D Wang","year":"2005","unstructured":"Wang D. Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease. Nature. 2005;306:5.","journal-title":"Nature"},{"key":"1206_CR2","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.2174\/138161212802481237","volume":"18","author":"A Tuttolomondo","year":"2012","unstructured":"Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G. Atherosclerosis as an inflammatory disease. Curr Pharm Des. 2012;18:4266\u201388.","journal-title":"Curr Pharm Des"},{"key":"1206_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1177\/039463201102400401","volume":"24","author":"A Anogeianaki","year":"2011","unstructured":"Anogeianaki A, Angelucci D, Cianchetti E, D'Alessandro M, Maccauro G, Saggini A, Salini V, Caraffa A, Tete S, Conti F, Tripodi D, Shaik-Dasthagirisaheb YB. Atherosclerosis: a classic inflammatory disease. Int J Immunopathol Pharmacol. 2011;24:817\u201325.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"1206_CR4","first-page":"1","volume":"19","author":"M Vaccarezza","year":"2018","unstructured":"Vaccarezza M, Balla C, Rizzo P. Atherosclerosis as an inflammatory disease: doubts? No more. Int J Cardiol Heart Vasc. 2018;19:1\u20132.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"1206_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/01.CIR.66.2.401","volume":"66","author":"RC Schlant","year":"1982","unstructured":"Schlant RC, Forman S, Stamler J, Canner PL. Circulation. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project. Circulation. 1982;66:401\u201314.","journal-title":"Circulation"},{"key":"1206_CR6","first-page":"207","volume":"21","author":"D Lao","year":"2009","unstructured":"Lao D, Yeghiazarians Y. Pre-PCI white blood cell count: should we care? J Invasive Cardiol. 2009;21:207\u20138.","journal-title":"J Invasive Cardiol"},{"key":"1206_CR7","first-page":"221","volume":"2","author":"SH Danesh Sani","year":"2014","unstructured":"Danesh Sani SH, Eshraghi A, Shahri B, Vejdanparast M. No-reflow phenomenon in patients with ST-elevation acute myocardial infarction, treated with primary percutaneous coronary intervention: a study of predictive factors. J Cardiothorac Med. 2014;2:221\u20136.","journal-title":"J Cardiothorac Med"},{"key":"1206_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2298\/VSP140223064M","volume":"72","author":"DM Mati\u0107","year":"2015","unstructured":"Mati\u0107 DM, A\u0161anin MR, SDj S, Mrdovi\u0107 IB, Marinkovi\u0107 JM, Ko\u010dev NI, Antonijevi\u0107 NM, Marjanovi\u0107 MM, Ne\u0161i\u0107 ZI, Prostran MS, Stankovi\u0107 GR. Incidence, predictors and prognostic implications of bleeding complicating primary percutaneous coronary intervention. Vojnosanit Pregl. 2015;72:589\u201395.","journal-title":"Vojnosanit Pregl"},{"key":"1206_CR9","first-page":"e25414","volume":"4","author":"S Abdi","year":"2015","unstructured":"Abdi S, Rafizadeh O, Peighambari M, Basiri H, Bakhshandeh H. Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention. Res Cardiovasc Med. 2015;4:e25414.","journal-title":"Res Cardiovasc Med"},{"issue":"1","key":"1206_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","volume":"79","author":"DJ Gordon","year":"1989","unstructured":"Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79(1):8\u201315.","journal-title":"Circulation"},{"key":"1206_CR11","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1161\/01.ATV.15.11.1882","volume":"15","author":"A Miyazaki","year":"1995","unstructured":"Miyazaki A, Sakuma S, Morikawa W, Takiue T, Miake F, Terano T, Sakai M, Hakamata H, Sakamoto Y, Natio M, et al. Author information intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1995;15:1882\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1206_CR12","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","volume":"100","author":"RK Tangirala","year":"1999","unstructured":"Tangirala RK, Tsukamoto K, Chun SH, Usher D, Pure E, Rader DJ. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation. 1999;100:1816\u201322.","journal-title":"Circulation"},{"key":"1206_CR13","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1161\/hc2501.092494","volume":"103","author":"PK Shah","year":"2001","unstructured":"Shah PK, Yano J, Reyes O, Chyu KY, Kaul S, Bisgaier CL, Drake S, Cercek B. High-dose recombinant apolipoprotein A-I (Milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation. 2001;103:3047\u201350.","journal-title":"Circulation"},{"key":"1206_CR14","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1161\/hc4501.098952","volume":"104","author":"JX Rong","year":"2001","unstructured":"Rong JX, Li J, Reis ED, Choudhury RP, Dansky HM, Elmalem VI, Fallon JT, Breslow JL, Fisher EA. Elevating high-density lipoprotein cholesterol in apolipoprotein E-deficient mice remodels advanced atherosclerotic lesions by decreasing macrophage and increasing smooth muscle cell content. Circulation. 2001;104:2447\u201352.","journal-title":"Circulation"},{"key":"1206_CR15","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1073\/pnas.1016086108","volume":"108","author":"JE Feig","year":"2011","unstructured":"Feig JE, Rong JX, Shamir R, Sanson M, Vengrenyuk Y, Liu J, Rayner K, Moore K, Garabedian M, Fisher EA. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. Proc Natl Acad Sci U S A. 2011;108:7166\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1206_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/01.CIR.85.4.1279","volume":"85","author":"PK Shah","year":"1992","unstructured":"Shah PK, Amin J. Low high density lipoproteinlevel is associated with increased restenosis rate after coronary angioplasty. Circulation. 1992;85:1279\u201385.","journal-title":"Circulation"},{"key":"1206_CR17","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.amjcard.2008.11.053","volume":"103","author":"ZB Ghazzal","year":"2009","unstructured":"Ghazzal ZB, Dhawan SS, Sheikh A, Douglas JS, Veledar E, Mavromatis K, Pohlel FK, Vaccarino V. Usefulness of serum high-density lipoprotein cholesterol level as an independent predictor of one-year mortality after percutaneous coronary interventions. Am J Cardiol. 2009;103:902\u20136.","journal-title":"Am J Cardiol"},{"key":"1206_CR18","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1161\/01.CIR.96.12.4349","volume":"96","author":"B De Geest","year":"1997","unstructured":"De Geest B, Zhao Z, Collen D, Holvoet P. Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice. Circulation. 1997;96:4349\u201356.","journal-title":"Circulation"},{"key":"1206_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2010.09.024","volume":"214","author":"Y Feng","year":"2011","unstructured":"Feng Y, Gordts SC, Chen F, Hu Y, Van Craeyveld E, Jacobs F, Carlier V, Feng Y, Zhang Z, Xu Q, Ni Y, De Geest B. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice. Atherosclerosis. 2011;214:271\u20138.","journal-title":"Atherosclerosis"},{"key":"1206_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacbts.2017.11.006","volume":"3","author":"LZ Vanags","year":"2018","unstructured":"Vanags LZ, Tan JTM, Galougahi KK, Schaefer A, Wise SG, Murphy A, Ali ZA, Bursill CA. Apolipoprotein A-I reduces in-stent restenosis and platelet activation and alters Neointimal cellular phenotype. JACC Basic Transl Sci. 2018;3:200\u20139.","journal-title":"JACC Basic Transl Sci"},{"key":"1206_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jjcc.2015.08.016","volume":"68","author":"S Tani","year":"2016","unstructured":"Tani S, Nagao K, Hirayama A. Association of systemic inflammation with the serum apolipoprotein A-1 level: a cross-sectional pilot study. J Cardiol. 2016;68:168\u201377.","journal-title":"J Cardiol"},{"key":"1206_CR22","doi-asserted-by":"publisher","first-page":"e47183","DOI":"10.1371\/journal.pone.0047183","volume":"7","author":"G Twig","year":"2012","unstructured":"Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B, Tirosh A. White blood cell count and the risk for coronary artery disease in young adults. PLoS One. 2012;7:e47183.","journal-title":"PLoS One"},{"issue":"6","key":"1206_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1055\/s-0039-1681103","volume":"119","author":"YY Zheng","year":"2019","unstructured":"Zheng YY, Wu TT, Chen Y, Hou XG, Yang Y, Ma X, Ma YT, Zhang JY, Xie X. Gamma-Glutamyl Transferase-to-platelet ratio as a novel predictor of long-term adverse outcomes in patients after undergoing percutaneous coronary intervention: a retrospective cohort study. Thromb Haemost. 2019;119(6):1021\u201330.","journal-title":"Thromb Haemost"},{"key":"1206_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1536\/jhj.44.201","volume":"44","author":"Y Takeda","year":"2003","unstructured":"Takeda Y, Suzuki S, Fukutomi T, Kondo H, Sugiura M, Suzumura H, Murasaki G, Okutani H, Itoh M. Elevated white blood cell count as a risk factor of coronary artery disease: inconsistency between forms of the disease. Jpn Heart J. 2003;44:201\u201311.","journal-title":"Jpn Heart J"},{"key":"1206_CR25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/01.ATV.0000257135.39571.5b","volume":"27","author":"ZA Ali","year":"2007","unstructured":"Ali ZA, Alp NJ, Lupton H, Arnold N, Bannister T, Hu Y, Mussa S, Wheatcroft M, Greaves DR, Gunn J, Channon KM. Increased in-stent stenosis in ApoE knockout mice: insights from a novel mouse model of balloon angioplasty and stenting. Arterioscler Thromb Vasc Biol. 2007;27:833\u201340.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1206_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1191\/1358863x03vm462oa","volume":"8","author":"FG Welt","year":"2003","unstructured":"Welt FG, Tso C, Edelman ER, Kjelsberg MA, Paolini JF, Seifert P, Rogers C. Leukocyte recruitment and expression of chemokines following different forms of vascular injury. Vasc Med. 2003;8:1\u20137.","journal-title":"Vasc Med"},{"key":"1206_CR27","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","volume":"290","author":"SE Nissen","year":"2003","unstructured":"Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA. 2003;290:2292\u2013300.","journal-title":"JAMA"},{"issue":"8","key":"1206_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1161\/01.RES.0000185320.82962.F7","volume":"97","author":"RE Moore","year":"2005","unstructured":"Moore RE, Navab M, Millar JS, Zimetti F, Hama S, Rothblat GH, Rader DJ. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation. Circ Res. 2005;97(8):763\u201371.","journal-title":"Circ Res"},{"issue":"5986","key":"1206_CR29","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1126\/science.1189731","volume":"328","author":"L Yvan-Charvet","year":"2010","unstructured":"Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S, Welch CL, Wang N, Randolph GJ, Snoeck HW, Tall AR. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010;328(5986):1689\u201393.","journal-title":"Science"},{"key":"1206_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2017.08.007","volume":"265","author":"H Wada","year":"2017","unstructured":"Wada H, Dohi T, Miyauchi K, Shitara J, Endo H, Doi S, Konishi H, Naito R, Tsuboi S, Ogita M, Kasai T, Hassan A, Okazaki S, Isoda K, Suwa S, Daida H. Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease. Atherosclerosis. 2017;265:35\u201340.","journal-title":"Atherosclerosis"},{"key":"1206_CR31","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1177\/1076029616663850","volume":"23","author":"A Ar\u0131soy","year":"2017","unstructured":"Ar\u0131soy A, Altunka\u015f F, Karaman K, Karayakal\u0131 M, \u00c7elik A, Ceyhan K, Zorlu \u00c7. Association of the Monocyte to HDL cholesterol ratio with Thrombus burden in patients with ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost. 2017;23:992\u20137.","journal-title":"Clin Appl Thromb Hemost"},{"key":"1206_CR32","unstructured":"Zegarra-Mondrag\u00f3n S, L\u00f3pez-Gonz\u00e1lez R, Mart\u00edn-Mart\u00ednez MA, Garc\u00eda-G\u00f3mez C, S\u00e1nchez-Alonso F, Gonz\u00e1lez-Juanatey C, Manrique Arija S, Bonilla Hern\u00e1n G, Mart\u00ednez Pardo S, Ruibal Escribano A, Pag\u00e1n Garc\u00eda E, Delgado Fr\u00edas E, Rivera Redondo J, Delgado S\u00e1nchez M, Rodriguez Cambr\u00f3n AB, Moreno Ramos MJ, Rodr\u00edguez Montero SA, Nav\u00edo Marco MT, Morcillo Valle M, Garc\u00eda Gonz\u00e1lez J, Bachiller Corral J, Llorca J, Casta\u00f1eda S, Gonz\u00e1lez-Gay M\u00c1; CARMA Project Collaborative Group. Association of apolipoprotein B\/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study. Clin Exp Rheumatol; 2019. [Epub ahead of print] PMID: 31694752."},{"issue":"1","key":"1206_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12944-019-1101-9","volume":"18","author":"BD Chen","year":"2019","unstructured":"Chen BD, Chen XC, Yang YN, Gao XM, Ma X, Huang Y, Li XM, Gai MT, Liu F, Pan S, Ma YT. Apolipoprotein A1 is associated with SYNTAX score in patients with a non-ST segment elevation myocardial infarction. Lipids Health Dis. 2019;18(1):159. https:\/\/doi.org\/10.1186\/s12944-019-1101-9.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"1206_CR34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-019-1144-y","volume":"18","author":"M Tian","year":"2019","unstructured":"Tian M, Li R, Shan Z, Wang DW, Jiang J, Cui G. Comparison of Apolipoprotein B\/A1 ratio, Framingham risk score and TC\/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention. Lipids Health Dis. 2019;18(1):202. https:\/\/doi.org\/10.1186\/s12944-019-1144-y.","journal-title":"Lipids Health Dis"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-020-01206-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:54:16Z","timestamp":1615856056000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-01206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-01206-w","relation":{},"ISSN":["1476-511X"],"issn-type":[{"type":"electronic","value":"1476-511X"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The ethics committee or review committee of the First Affiliated Hospital of Xinjiang Medical University approved the research protocol. Because the study was a retrospective cohort study based on real-world situations, there was no need to obtain informed consent from patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publication of this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No potential conflicts of interest relevant to this article were reported by any of the authors. None of the funding sources played a role in the design, collection, analysis or interpretation of the data or in the decision to submit the manuscript for publication. The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}